A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors.

A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors.

Item
http://www.wikidata.org/entity/Q33391571
Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumoursClinical indications for thrombopoietin and thrombopoietin-receptor agonistsAlternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.Assessment of the pharmacokinetic interaction between eltrombopag and lopinavir-ritonavir in healthy adult subjects.Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiationResults of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamidePopulation PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia.Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I studyThe pharmacology and clinical application of thrombopoietin receptor agonists.From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study.Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient.Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia
P2860

A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors.

Item
http://www.wikidata.org/entity/Q33391571
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
A randomized, double-blind, pl ...... xel for advanced solid tumors.
@ast
A randomized, double-blind, pl ...... xel for advanced solid tumors.
@en
type
label
A randomized, double-blind, pl ...... xel for advanced solid tumors.
@ast
A randomized, double-blind, pl ...... xel for advanced solid tumors.
@en
prefLabel
A randomized, double-blind, pl ...... xel for advanced solid tumors.
@ast
A randomized, double-blind, pl ...... xel for advanced solid tumors.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
A randomized, double-blind, pl ...... axel for advanced solid tumors
@en
P2093
P304
P31
P356
10.1185/03007995.2010.510051
P407
P433
P478
P50
P577
P698
P921